SofWave Medical
在场
SofWave Medical 是一家在股票代码 SOFW (IL) 下上市的公司。
高管
查看带有其 25 名主要高管的组织结构图
SofWave Medical 搜索最多的简介
- Louis Scafuri, Chief Executive Officer
- Shimon Eckhouse, Chairman of the Board
- Genady Nahshon, Chief Operating Officer and Site Manager
高管在SofWave Medical变化
- Miguel Pardos已作为Chief Commercial Officer加入公司 (新闻发布的2024十一月14号).
- Larry Laber已作为Executive Vice President, North American Sales加入公司 (新闻发布的2024九月5号).
创建提醒
跟踪 SofWave Medical 的高管变动
生物技术
SofWave Medical 拥有 2,327 家竞争者，其中包括 Eurofins (卢森堡)、Lonza (瑞士) 和 Biogen (美国(美洲))。
Popular M&A news in 生物技术
- Chromocell的新名称是Channel Therapeutics Corporation。 (公布2024十一月22号).
- Enveda Biosciences 刚刚宣布为 130 筹款数百万美元。 (公布2024十一月22号).
- Alentis Therapeutics 刚刚宣布为 181 筹款数百万美元。 (公布2024十一月20号).
生物技术 行业的其他推荐联系人
消息
SofWave Medical 的最新新闻稿
- Sofwave Medical Reports Third Quarter 2024 Financial Results and Business Highlights
- Dr. Kavita Darji Wins the Drs. Alastair and Jean D. Carruthers Award at ASDS 2024 for Sofwave SUPERB™ Abstract
- Sofwave Names Larry Laber, Aesthetic Energy-Based Device Sales Veteran, to Role of Executive Vice President, North American Sales
- Sofwave Receives FDA Clearance for Pure ImpactTM in Strengthening and Firming of Arms in the U.S
- Sofwave Medical Reports Second Quarter and First Half 2024 Financial Results and Business Highlights
- Sofwave Medical Reports First Quarter 2024 Financial Results and Business Highlights
- Sofwave Medical Reports Fourth Quarter and Full Year 2023 Financial Results and Business Highlights
- Sofwave Medical Appoints Medical Aesthetics Industry Expert James Bartholomeusz to the Role of Chief Innovation Officer
- Sofwave Medical Receives 510(k) Marketing Clearance For Pure Impact™ Strength and Muscle Toning Body Module Utilizing PlyoPulse™ EMS Technology
- Sofwave Medical Receives FDA Clearance of SUPERB™ Technology For Improvement of the Appearance of Skin Laxity on the Upper Arm
- View more press releases Close
通过电子邮件
